Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mef Nilbert

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Molecular Genetics & Genomic Medicine|August 1, 2014
Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair proteinMev Dominguez-Valentin, Mark Drost, Christina Therkildsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 28, 2020
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer careMef Nilbert, Linda Aagaard Thomsen, Jens Winther Jensen, et al.
Familial Cancer|October 4, 2016
Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testingAnna Rohlin, Eva Rambech, Anders Kvist, et al.
Cancer|May 13, 2004
Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomasJacob Engellau, Harald Anderson, Anders Rydholm, et al.
Plos Genetics|November 1, 2017
Genetic anticipation in Swedish Lynch syndrome familiesJenny von Salomé, Philip S Boonstra, Masoud Karimi, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2004
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67Jacob Engellau, Annette Persson, Pär-Ola Bendahl, et al.
Plos One|September 17, 2014
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypesJenny-Maria Jönsson, Ida Johansson, Mev Dominguez-Valentin, et al.
Familial Cancer|February 3, 2016
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish populationHenriette Roed Nielsen, Mef Nilbert, Janne Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancerElise Renkonen, Yange Zhang, Hannes Lohi, et al.
British Journal of Cancer|August 26, 2016
Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention studyFredrik Liedberg, Ulf Gerdtham, Katarina Gralén, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Molecular Genetics & Genomic Medicine|August 1, 2014
Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair proteinMev Dominguez-Valentin, Mark Drost, Christina Therkildsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 28, 2020
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer careMef Nilbert, Linda Aagaard Thomsen, Jens Winther Jensen, et al.
Familial Cancer|October 4, 2016
Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testingAnna Rohlin, Eva Rambech, Anders Kvist, et al.
Cancer|May 13, 2004
Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomasJacob Engellau, Harald Anderson, Anders Rydholm, et al.
Plos Genetics|November 1, 2017
Genetic anticipation in Swedish Lynch syndrome familiesJenny von Salomé, Philip S Boonstra, Masoud Karimi, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2004
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67Jacob Engellau, Annette Persson, Pär-Ola Bendahl, et al.
Plos One|September 17, 2014
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypesJenny-Maria Jönsson, Ida Johansson, Mev Dominguez-Valentin, et al.
Familial Cancer|February 3, 2016
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish populationHenriette Roed Nielsen, Mef Nilbert, Janne Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancerElise Renkonen, Yange Zhang, Hannes Lohi, et al.
British Journal of Cancer|August 26, 2016
Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention studyFredrik Liedberg, Ulf Gerdtham, Katarina Gralén, et al.
Pageof 17